Craig Millian

Craig Millian

Chief Executive Officer en HLS THERAPEUTICS INC. .

Fortuna: 64 616 $ al 31/03/2024

56 años
Health Technology
Consumer Services

Perfil

Craig Millian is currently the Chief Executive Officer & Director at HLS Therapeutics, Inc. Prior to this, he was the Chief Operating Officer at Corbus Pharmaceuticals Holdings, Inc. from 2021 to 2023.
He was also the Senior Vice President-Neurology & Immunology at EMD Serono, Inc. from 2016 to 2018.
Before that, he worked as the Vice President-Commercial at Vertex Pharmaceuticals, Inc. Mr. Millian has an undergraduate degree from the University of Pennsylvania and an MBA from New York University.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
13/02/2023 900 ( 0.01% ) 35 316 $ 31/03/2024
16/11/2023 10 000 ( 0.03% ) 29 300 $ 31/03/2024

Cargos activos de Craig Millian

EmpresasCargoInicio
HLS THERAPEUTICS INC. Chief Executive Officer 01/05/2023
Todos los cargos activos de Craig Millian

Antiguos cargos conocidos de Craig Millian.

EmpresasCargoFin
CORBUS PHARMACEUTICALS HOLDINGS, INC. Chief Operating Officer 14/04/2023
Corporate Officer/Principal 01/12/2018
VERTEX PHARMACEUTICALS INCORPORATED Corporate Officer/Principal -
Ver el detalle de la experiencia de Craig Millian.

Formación de Craig Millian.

University of Pennsylvania Undergraduate Degree
New York University Masters Business Admin

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Craig Millian.

Relaciones

65

Relaciones de 1er grado

6

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas2
VERTEX PHARMACEUTICALS INCORPORATED

Health Technology

CORBUS PHARMACEUTICALS HOLDINGS, INC.

Health Technology

Empresas privadas2

Health Technology

HLS Therapeutics, Inc.

Ver las conexiones de la empresa